홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Trifluoroacetic acid → 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-(2-(pyridin-3-ylamino)ethylamino)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoic acid

HRID 85678
인쇄

반응식

HRID 85678 반응식
Br[C:2]1[CH:3]=[N:4][CH:5]=[CH:6][CH:7]=1.CC(C)([O-])C.[Na+].C1COCC1.Cl.Cl.[NH2:21][CH2:22][CH2:23][NH:24][C@:25]12[CH2:60][CH2:59][C@@H:58]([C:61]([CH3:63])=[CH2:62])[C@@H:26]1[C@@H:27]1[C@@:40]([CH3:43])([CH2:41][CH2:42]2)[C@@:39]2([CH3:44])[C@@H:30]([C@:31]3([CH3:57])[C@@H:36]([CH2:37][CH2:38]2)[C:35]([CH3:46])([CH3:45])[C:34]([C:47]2[CH:56]=[CH:55][C:50]([C:51]([O:53]C)=[O:52])=[CH:49][CH:48]=2)=[CH:33][CH2:32]3)[CH2:29][CH2:28]1.O.[OH-].[Li+].C(O)(C(F)(F)F)=O>COCCOC.C([O-])(=O)C.[Pd+2].C([O-])(=O)C.CO.O>[CH3:43][C@:40]12[C@@:39]3([CH3:44])[C@@H:30]([C@:31]4([CH3:57])[C@@H:36]([CH2:37][CH2:38]3)[C:35]([CH3:45])([CH3:46])[C:34]([C:47]3[CH:56]=[CH:55][C:50]([C:51]([OH:53])=[O:52])=[CH:49][CH:48]=3)=[CH:33][CH2:32]4)[CH2:29][CH2:28][C@@H:27]1[C@H:26]1[C@H:58]([C:61]([CH3:63])=[CH2:62])[CH2:59][CH2:60][C@:25]1([NH:24][CH2:23][CH2:22][NH:21][C:2]1[CH:3]=[N:4][CH:5]=[CH:6][CH:7]=1)[CH2:42][CH2:41]2
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

11

반응물 6

HCID 6422Trifluoroacetic acidHCID 8028TetrahydrofuranHCID 122863-BromopyridineHCID 168937Lithium hydroxide, monohydrateHCID 23676156Sodium t-butoxideHCID 131731915
methyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-(2-amino ethylamino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoate bis HCl salt

생성물 1

HCID 683582194-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-3a-(2-(pyridin-3-ylamino)ethylamino)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoic acid수율 82.4%

시약·촉매·용매 4

HCID 167845palladium(II) acetate촉매HCID 887Methanol용매HCID 962Water용매HCID 80711,2-Dimethoxyethane용매2회

반응 조건

온도
110 °C

실험 절차

In a 1 dram vial under nitrogen were combined (2R)-1-[(1R)-1-[bis(1,1-dimethylethyl)phosphino]ethyl]-2-(dicyclohexylphosphino)ferrocene (CAS#158923-11-6) (2.101 mg, 3.79 mmol), palladium(II) acetate (0.851 mg, 3.79 mmol) and dry DME (0.5 ml). The contents of the vial were stirred for 10 min, and were then added all at once to a separate mixture of 3-bromopyridine (0.014 g, 0.091 mmol) and sodium tert-butoxide, 2.0M solution in THF (0.167 mL, 0.333 mmol) in dry DME (0.333 mL) contained in a separate 1 dram vial. The resulting mixture was allowed to stir very briefly (1 min) before solid methyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-(2-aminoethylamino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoate bis HCl salt (0.050 g, 0.076 mmol) was added in one portion. The mixture was heated to 110° C. overnight. To the mixture was added lithium hydroxide monohydrate (6.4 mg, 0.152 mmol) with water (0.2 mL) and methanol (0.5 mL) and the resulting mixture was stirred for 4 days. Purification of the crude mixture by reverse phase preparative HPLC using Prep HPLC Method 7 gave the title compound (0.0407 g, 57.5% yield) as a beige powder bis TFA salt. LCMS: m/e 650.4 (M+H)+, 2.26 min (method 11). 1H NMR (500 MHz, 1:1 mixture of CDCl3 and MeOD, MeOD lock) δ ppm 8.26 (d, J=2.4 Hz, 1H), 8.02 (d, J=4.9 Hz, 1H), 7.94-7.87 (m, J=8.2 Hz, 2H), 7.77 (dd, J=8.9, 1.5 Hz, 1H), 7.67 (dd, J=8.9, 5.2 Hz, 1H), 7.22-7.14 (m, 2H), 5.28 (dd, J=6.3, 1.7 Hz, 1H), 4.82 (s, 1H), 4.74 (s, 1H), 3.89-3.78 (m, 1H), 3.70 (dt, J=14.6, 4.5 Hz, 1H), 3.30-3.23 (m, 2H), 2.85 (td, J=11.1, 5.5 Hz, 1H), 2.21-2.05 (m, 3H), 2.03-1.94 (m, 2H), 1.94-1.85 (m, 1H), 1.85-1.76 (m, 1H), 1.72 (s, 3H), 1.70-1.64 (m, 1H), 1.64-1.51 (m, 3H), 1.51-1.44 (m, 3H), 1.43-1.20 (m, 6H), 1.19-1.08 (m, 2H), 1.07-1.04 (m, 3H), 1.04-1.00 (m, 3H), 0.99 (s, 3H), 0.95-0.88 (m, 7H).

후처리

  1. additionwere then added all at
  2. additionwas added in one portion
  3. stirringthe resulting mixture was stirred for 4 days
  4. customPurification of the crude mixture by reverse phase preparative HPLC

출처 및 근거

ORD 기록
ord-7118a8a31248428ebc8af8880c0f714d
출처 데이터셋
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08846647B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트